MeiraGTx Holdings Plc

How big is MeiraGTx Holdings Plc?

As of Jun 18, MeiraGTx Holdings Plc has a market capitalization of 508.71 million, with net sales of 34.51 million and a net profit of -167.33 million over the latest four quarters. Shareholder's funds are 67.83 million, and total assets amount to 269.75 million as of Dec 24.

As of Jun 18, MeiraGTx Holdings Plc has a market capitalization of 508.71 million, categorizing it as a Micro Cap company.<BR><BR>As of Jun 18, the sum of Net Sales for the latest four quarters is 34.51 million, while the sum of Net Profit for the same period is -167.33 million.<BR><BR>As of Dec 24, the reporting period shows Shareholder's Funds of 67.83 million and Total Assets of 269.75 million.

What does MeiraGTx Holdings Plc do?

MeiraGTx Holdings Plc is a clinical-stage gene therapy company focused on developing treatments for inherited and acquired disorders. As of March 2025, it reported net sales of $2 million and a net loss of $40 million, with a market cap of $508.71 million.

Overview:<BR>MeiraGTx Holdings Plc is a clinical-stage gene therapy company in the Pharmaceuticals & Biotechnology industry, focused on developing gene therapy treatments for inherited and acquired disorders.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 2 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: -40 Million (Quarterly Results - Mar 2025) <BR>Market cap: USD 508.71 Million (Micro Cap) <BR><BR>Key Metrics:<BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 0.00% <BR>Debt Equity: 0.31 <BR>Return on Equity: -505.54% <BR>Price to Book: 15.37 <BR><BR>Contact Details:<BR>Address: 450 E 29th St Fl 15, NEW YORK NY: 10016-8367 <BR>Tel: 1 646 8607983 <BR>Website: http://meiragtx.com/

Should I buy, sell or hold MeiraGTx Holdings Plc?

Who are in the management team of MeiraGTx Holdings Plc?

As of March 2022, the management team of MeiraGTx Holdings Plc includes Dr. Keith Harris (Independent Chairman), Dr. Alexandria Forbes (President and CEO), and several Independent Directors: Ms. Ellen Hukkelhoven, Mr. Martin Indyk, Dr. Arnold Levine, Mr. Joel Marcus, and Mr. Neil Mendoza. They are responsible for the company's strategic direction.

As of March 2022, the management team of MeiraGTx Holdings Plc includes the following individuals:<BR><BR>- Dr. Keith Harris, who serves as the Independent Chairman of the Board.<BR>- Dr. Alexandria Forbes, who is the President, Chief Executive Officer, and Director.<BR>- Ms. Ellen Hukkelhoven, an Independent Director.<BR>- Mr. Martin Indyk, an Independent Director.<BR>- Dr. Arnold Levine, an Independent Director.<BR>- Mr. Joel Marcus, an Independent Director.<BR>- Mr. Neil Mendoza, an Independent Director. <BR><BR>This team is responsible for guiding the strategic direction of the company.

Is MeiraGTx Holdings Plc overvalued or undervalued?

As of August 7, 2019, MeiraGTx Holdings Plc is considered risky due to its overvaluation and poor financial metrics, including a Price to Book Value of 14.57, negative EV to EBITDA, and significantly low ROCE and ROE, despite a strong year-to-date return of 31.20% compared to the S&P 500's 12.22%.

As of 7 August 2019, the valuation grade for MeiraGTx Holdings Plc moved from does not qualify to risky, indicating increased concerns about its financial health. The company appears to be overvalued given its significant negative performance metrics, including a Price to Book Value of 14.57 and an EV to EBITDA of -3.36. Additionally, the company's ROCE and ROE are alarmingly low at -366.71% and -505.54%, respectively, which further supports the overvaluation thesis.<BR><BR>In comparison to its peers, MeiraGTx's EV to EBITDA ratio of -4.4399 is worse than Voyager Therapeutics, which stands at -0.2378, and MaxCyte at -0.5242. Furthermore, while MeiraGTx has shown a strong YTD return of 31.20% compared to the S&P 500's 12.22%, its long-term performance is concerning, with a 5-year return of -40.95% versus the S&P 500's 96.61%. This discrepancy highlights the risks associated with investing in MeiraGTx Holdings Plc.

Is MeiraGTx Holdings Plc technically bullish or bearish?

As of October 10, 2025, MeiraGTx Holdings Plc shows a mildly bullish trend overall, despite mixed signals from various indicators, suggesting caution in investment decisions.

As of 10 October 2025, the technical trend for MeiraGTx Holdings Plc has changed from bullish to mildly bullish. The weekly MACD is mildly bearish, while the monthly MACD is bullish, indicating mixed signals. The Bollinger Bands and Dow Theory both show a mildly bullish stance on the weekly and monthly time frames. Daily moving averages are also mildly bullish. However, the KST shows a bearish signal weekly but bullish monthly, and the OBV is mildly bullish weekly but mildly bearish monthly. Overall, the indicators suggest a mildly bullish stance, though the mixed signals indicate caution. There is no available return data for comparison with the S&P 500.